Objective: Although there is increased survival and quality of life for thalassemia patients, which results from a genetic defect in globin synthesis, heart diseases are still important causes of morbidity and mortality related to the iron burden. Therefore, we aimed to evaluate the cardiac functions of thalassemia patients followed up in Hatay State Hospital using echocardiography. Method: A total of 101 patients with 7 thalassemia intermedia and 94 thalassemia major who were followed at Hatay state hospital were examined retrospectively. Of patients, 47 were male and 54 were female. Their ages ranged between 1-17 years (mean 8.6±4.6 years). M-mode echocardiography was used to measure LVEDd (left ventricular enddiastolic diameter) and EF (ejection fraction). The demographic and laboratory values of the patients were obtained from their files. Results: The mean of LVEDd (mm) and EF (%) were evaluated as 34.8±6.1, and 66.36±1.4 with M-mode echocardiography, respectively. When the correlation between age, ferritin and LVEDd and EF were evaluated; it was determined that there was a high positive correlation (r=0.649) between age and LVEDd (p<0.01). A negative correlation was detected between ferritin and EF (r=-0.271) (p<0.01). EF was found to be significantly lower in the group with ferritin <2000. LVEDd was found to be increased in the group with ferritin >2000, although it was not statistically significant. Conclusions: In our study, it was shown that EF was decreased with increasing ferritin and LVEDS was increased with increasing age of patients with thalassemia. The ideal ferritin level which was ensured after suitable chelation therapy should be an important goal to reduce cardiac involvement.
INTRODUCTION
Thalassemia is a disease characterized by hypochromic microcytic anemia development as a result of low or no synthesis of the hemoglobin (Hb) chain defined as α, β, γ and δ. Thalassemia carriers are divided into two subgroups of thalassemia intermedia and thalassemia major. Thalassemia major, especially, may have a severe clinical tableau dependent on transfusions 1 . In thalassemia major patients, transfusion-linked iron accumulation is responsible for morbidity and mortality. Iron accumulation, especially, may cause cardiac complications like pericarditis, myocarditis, or congestive heart failure and mortality at advanced age. Ferritin is the most common biochemical parameter used to assess iron accumulation. Studies have found that patients with continuously high ferritin levels (>2500 ng/mL) have high rates of cardiac effects. Especially in patients with low ferritin (<1000 ng/mL) cardiac problems were identified to be low 2 .
The results of studies from recent years have reported left ventricular diastolic function disorder is responsible for many heart diseases. In fact, it was identified that diastolic function was affected before the development of systolic function disorder 3,4 . Echocardiography is a method used to assess both systolic and diastolic function 5 .
As a result, in this research we aimed to investigate transfusion-dependent patients monitored by the thalassemia unit with both thalassemia major and intermedia with echocardiographic investigation to assess cardiac findings and research correlations with serum ferritin and demographic information.
MATERIAL AND METHODS

Study Group
The study included a total of 101 patients, 7 with thalassemia intermedia and 94 with thalassemia major, monitored by Hatay State Hospital thalassemia unit aged less than 18 years, receiving regular blood transfusions and without known congenital or acquired heart disease. Of patients, 47 were male and 54 were female with ages ranging from 1 to 17 years (mean 8.6±4.6 years).
Hematologic Assessment
Patient demographic characteristics were obtained from the monitoring cards in the thalassemia unit. Patients had transfusion with an erythrocyte suspension every 3-6 weeks to ensure pretransfusion hemoglobin levels were 9-9.5 g/dL. All patients used 20-40 mg/kg/day deferasirox and folbiol by the oral route.
Cardiac Assessment
Echocardiographic Study
Two-dimensional M-mode echocardiography studies were performed using a Toshiba SSH-160A echocardiograph and 3.75, 5 and 1.5 mHz transducer.
During echocardiographic investigation simultaneous ECG and phonocardiogram records were taken, with all measurements taken separately during at least 3 cardiac cycles and mean values calculated.
M-mode echocardiographic investigation recorded left ventricular end diastolic diameter (LVEDd) and ejection fraction (EF) calculated by the device.
For statistical analysis of results, the t test and
Pearson's correlation test were used.
RESULTS
M-mode echocardiographic evaluations of a total of 101 patients identified LVEDd (mm) as mean 34.8±6.1, and mean EF (%) as 66.36±1.4.
The systolic functions examined with m-mode echocardiography for 101 thalassemia patients and their ferritin levels were compared as above and below 2000. Left ventricular systolic function measurements of EF were identified to be statistically significantly low (p=0.021) (Table 1) . There was no significant difference identified for LVEDd. Table 2 shows the age and left ventricular systolic function measurements for thalassemia patients. Thalassemia patients aged over 12 years were identified to have a statistical increase in LVEDd (p=0.001). Table 3 shows the left ventricular systolic function measurements for thalassemia patients with sex. LVEDd (mm) was identified to show a statistically significant increase in male thalassemia patients (p=0.001). 
DISCUSSION
The most common cause of death in transfusiondependent thalassemia patients is heart failure. Both increased gastrointestinal iron absorption and severe chronic anemia and resulting increase iron burden linked to blood transfusions cause myocardial iron accumulation leading to cardiac involvement 6 . Thalassemia patients survive a mean of 1 year from the occurrence of clinical symptoms of cardiac involvement. As a result, identification of cardiac involvement in the early period will be important to reduce mortality rates.
A study by Nazan 8 . In our study, the EF values in thalassemia major patients were identified to be lower compared to the patient and control group in this study. However, none of our patients were identified to have EF value below 50%. In conclusion, though our patients had not developed left ventricular dysfunction, they were determined to be at risk of developing heart failure due to low EF values. As a result, the need to take precautions to reduce iron accumulation was demonstrated.
Ferritin is known as an important biochemical parameter showing iron accumulation in the body of thalassemia patients. Especially those with ferritin >1000 ng/mL have increased complication risk so it is recommended that chelation treatment begin with appropriate dose and appropriate administration form 9 . A study by Behzad et al. did not identify a difference in LVEDd while EF was low in thalassemia major patients with high ferritin 10 . Another study assessed cardiac functions of thalassemia major patients according to ferritin values (ferritin above and below 2500) and did not observe significant differences in both systolic and diastolic functions 11 . In our study, EF was identified to be lower in those with ferritin >2000 ng/mL. As age increased, an LVEDd increase was identified, while male sex was determined to show increased LVEDd.
In conclusion, it is important that necessary precautions are taken to determine the onset of disrupted cardiac functions before cardiac failure develops in thalassemia patients. As a result, all thalassemia patients should have echocardiography performed annually and if there are disruptions in measurements like EF or LVEDd, more frequent echocardiography checkups should be planned. Based on ferritin monitoring and changes in echocardiographic findings, early appropriate dose chelation should begin which will be an appropriate method to prevent development of cardiac failure.
